Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
- Mar 28
Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update
-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds-...
- Mar 22
Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of Directors
JERUSALEM, March 21, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Mar 8
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
Alpha Tau Is Expected to Commence Trading on Nasdaq Under the Ticker "DRTS" on March 8, 2022 JERUSALEM and WILMINGTON, Del., March 7,...
- Jan 20
New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer
JERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Jan 10
Results of First US Clinical Trial of Alpha DaRT™
Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...
- Jan 3
Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
JERUSALEM, Dec. 31, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Jan 2
Alpha DaRT Investigator Meeting in Las Vegas
Coming Up Soon - Alpha DaRT Investigator Meeting in Las Vegas Alpha Tau is pleased to announce that the Alpha DaRT Investigator Meeting,...
- Nov 4, 2021
Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)
JERUSALEM, Nov. 3, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Oct 26, 2021
Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective
JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Oct 12, 2021
Meet Alpha Tau at ASTRO Chicago 2021
We are thrilled to announce that the Alpha Tau team will be attending (IN PERSON this year - Finally ! ) the ASTRO conference in Chicago....